We therefore set out to test whether the published ASCT2 inhibitor, Benzylserine (BenSer), which we have previously shown can also inhibit leucine uptake by LAT1 in melanoma cells [8], would be an effective inhibitor of breast cancer cell growth. The gene discussed is SLC7A5; the disease is breast carcinoma.